Skip to content

The effect of intravenous administration of magnesium sulfate on immune function in patients undergoing elective coronary bypass graft without cardiopulmonary bypass.

The effect of intravenous administration of magnesium sulfate on immune function in patients undergoing elective coronary bypass graft without cardiopulmonary bypass.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INC-16007761
Enrollment
Unknown
Registered
2016-01-14
Start date
2016-01-10
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary heart disease

Interventions

Group A:infusion of magnesium sulfate
Group C:Infusion of normal saline

Sponsors

North China Grid Company Limited Beijing Electric Power Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The patients aged 30-65 who undergoing elective coronary bypass graft without cardiopulmonary bypass.

Exclusion criteria

Exclusion criteria: 1. Underlying heart failure (right sided or left sided, including low left ventricular ejection fraction, ie. preoperative LVEF < 25%); 2. Underlying renal disease; 3. Underlying diabetes mellitus; 4. Underlying uncontrolled hypertension; 5. Underlying thyroid problems (hypo/hyperthyroidism, active or controlled); 6. Underlying malabsorption (active or controlled); 7. Underlying untreated arrhythmias; 8. Underlying inflammatory disease (active or controlled); 9. Underlying uncorrected magnesium or calcium abnormalities, Emergent or urgent CABG; 10. Patient refusal to enter or continue study; 11. QTc interval abnormalities (including Torsades de pointes syndrome); 12. Co-administration of steroids, statins, aspirin/anti-inflammatory agents.

Design outcomes

Primary

MeasureTime frame
Th1;Th2;Th3;Th17;

Countries

China

Contacts

Public ContactGuoyan Li
liguoyanbeijing@163.com+86 010 63502720

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026